Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization

Neuron

Volumn 38, Issue 5, 2003, Pages 747-758

  Saito, Fumiaki ^a   Moore, Steven A ^b   Barresi, Rita ^a   Henry, Michael D ^a   Messing, Albee ^c   Ross Barta, Susan E ^b   Cohn, Ronald D ^a   Williamson, Roger A ^b   Sluka, Kathleen A ^b   Sherman, Diane L ^d   Brophy, Peter J ^d   Schmelzer, James D ^e   Low, Phillip A ^e   Wrabetz, Lawrence ^f   Feltri, M Laura ^f   Campbell, Kevin P ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e MAYO CLINIC   (United States)

^f SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; SODIUM CHANNEL;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; GENE DELETION; MICROVILLUS; MOUSE; MYELIN SHEATH; MYELINATION; NERVE CONDUCTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHWANN CELL; STEREOCHEMISTRY;

EID: 0037709890     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00301-5     Document Type: Article

References (63)

1. Allamand V., Sunada Y., Salih M.A., Straub V., Ozo C.O., Al-Turaiki M.H., Akbar M., Kolo T., Colognato H., Zhang X.et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. Hum. Mol. Genet. 6:1997;747-752.
2. Berthold C.-H., Rydmark M. Electron microscopic serial section analysis of nodes of Ranvier in lumbosacral spinal roots of the cat. ultrastructural organization of nodal compartments in fibres of different sizes J. Neurocytol. 12:1983;475-505.
3. Bhat M.A., Rios J.C., Lu Y., Garcia-Fresco G.P., Ching W., St Martin M., Li J., Einheber S., Chesler M., Rosenbluth J.et al. Axon-glia interactions and the domain organization of myelinated axons require neurexin IV/Caspr/Paranodin. Neuron. 30:2001;369-383.
4. Boerkoel C.F., Takashima H., Stankiewicz P., Garcia C.A., Leber S.M., Rhee-Morris L., Lupski J.R. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am. J. Hum. Genet. 68:2001;325-333.
5. Boyle M.E., Berglund E.O., Murai K.K., Weber L., Peles E., Ranscht B. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron. 30:2001;385-397.
6. Bozic D., Engel J., Brancaccio A. Sequence analysis suggests the presence of an IG-like domain in the N-terminal region of alpha-dystroglycan which was crystallized after mutation of a protease susceptible site (Arg168→His). Matrix Biol. 17:1998;495-500.
7. Bradley W.G., Jenkison M. Abnormalities of peripheral nerves in murine muscular dystrophy. J. Neurol. Sci. 18:1973;227-247.
8. Bradley W.G., Jenkison M. Neural abnormalities in the dystrophic mouse. J. Neurol. Sci. 25:1975;249-255.
9. Bradley W.G., Jaros E., Jenkison M. The nodes of Ranvier in the nerves of mice with muscular dystrophy. J. Neuropathol. Exp. Neurol. 36:1977;797-806.
10. Bunge M.B. Schwann cell regulation of extracellular matrix biosynthesis and assembly. Dyck P.J., Thomas P.K., Griffin J., Low P.A., Poduslo J. Peripheral Neuropathy. 1993;F. Saunders, Philadelphia. 299-316.pp.
11. Byers T., Lidov H.G., Kunkel L.M. An alternative dystrophin transcript specific to peripheral nerve. Nat. Genet. 4:1993;77-81.
12. Chance P.F. Overview of hereditary neuropathy with liability to pressure palsies. Ann. N Y Acad. Sci. 883:1999;14-21.
13. Ching W., Zanazzi G., Levinson S.R., Salzer J.L. Clustering of neuronal sodium channels requires contact with myelinating Schwann cells. J. Neurocytol. 28:1999;295-301.
14. Cohn R.D., Campbell K.P. Molecular basis of muscular dystrophies. Muscle Nerve. 23:2000;1456-1471.
15. Cohn R.D., Henry M.D., Michele D.E., Barresi R., Saito F., Moore S.A., Flanagan J.D., Skwarchuk M.W., Robbins M.E., Mendell J.R.et al. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 110:2002;639-648.
16. Duclos F., Straub V., Moore S.A., Venzke D.P., Hrstka R.F., Crosbie R.H., Durbeej M., Lebakken C.S., Ettinger A.J., van der Meulen J.et al. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J. Cell Biol. 142:1998;1461-1471.
17. Dupree J.L., Girault J.A., Popko B. Axo-glial interactions regulate the localization of axonal paranodal proteins. J. Cell Biol. 147:1999;1145-1152.
18. Durbeej M., Cohn R.D., Hrstka R.F., Moore S.A., Allamand V., Davidson B.L., Williamson R.A., Campbell K.P. Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol. Cell. 5:2000;141-151.
19. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:1993;809-823.
20. Fannon A.M., Sherman D.L., Ilyina-Gragerova G., Brophy P.J., Friedrich V.L. Jr., Colman D.R. Novel E-cadherin-mediated adhesion in peripheral nerve. Schwann cell architecture is stabilized by autotypic adherens junctions J. Cell Biol. 129:1995;189-202.
21. Feltri M.L., D'Antonio M., Previtali S., Fasolini M., Messing A., Wrabetz L. P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann. N Y Acad. Sci. 883:1999;116-123.
22. Feltri M.L., Porta D.G., Previtali S., Nodari A., Migliavacca B., Cassetti A., LittleWood-Evans A., Reichardt L., Messing A., Quattrini A., Mueller U., Wrabetz L. Conditional disruption of β1 integrin in Schwann cells impedes interaction with axons. J. Cell Biol. 156:2002;199-209.
23. Frei R., Dowling J., Carenini S., Fuchs E., Martini R. Myelin formation by Schwann cells in the absence of beta4 integrin. Glia. 27:1999;269-274.
24. Gillespie C.S., Sherman D.L., Fleetwood-Walker S.M., Cottrell D.F., Tait S., Garry E.M., Wallace V.C., Ure J., Griffiths I.R., Smith A., Brophy P.J. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron. 26:2000;523-531.
25. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 265:1994;103-106.
26. Guilbot A., Williams A., Ravise N., Verny C., Brice A., Sherman D.L., Brophy P.J., LeGuern E., Delague V., Bareil C.et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum. Mol. Genet. 10:2001;415-421.
27. Henry M.D., Satz J.S., Brakebusch C., Costell M., Gustafsson E., Fassler R., Campbell K.P. Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization. J. Cell Sci. 114:2001;1137-1144.
28. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702.
29. Imamura M., Araishi K., Noguchi S., Ozawa E. A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system. Hum. Mol. Genet. 9:2000;3091-3100.
30. Ishibashi T., Dupree J.L., Ikenaka K., Hirahara Y., Honke K., Peles E., Popko B., Suzuki K., Nishino H., Baba H. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J. Neurosci. 22:2002;6507-6514.
31. Jaros E., Bradley W.G. Atypical axon-Schwann cell relationships in the common peroneal nerve of the dystrophic mouse. an ultrastructural study Neuropathol. Appl. Neurobiol. 5:1979;133-147.
32. Jung D., Yang B., Meyer J., Chamberlain J.S., Campbell K.P. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J. Biol. Chem. 270:1995;27305-27310.
33. Komiyama A., Novicki D.L., Suzuki K. Adhesion and proliferation are enhanced in vitro in Schwann cell from nerve undergoing Wallerian degeneration. J. Neurosci. Res. 29:1991;308-318.
34. Low P.A., Tuck R.R., Dyck P.J., Schmelzer J.D., Yao J.K. Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc. Natl. Acad. Sci. USA. 81:1984;6894-6898.
35. Masaki T., Matsumura K., Saito F., Sunada Y., Shimizu T., Yorifuji H., Motoyoshi K., Kamakura K. Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration. Acta Neuropathol. (Berl.). 99:2000;289-295.
36. Masaki T., Matsumura K., Hirata A., Yamada H., Hase A., Arai K., Shimizu T., Yorifuji H., Motoyoshi K., Kamakura K. Expression of dystroglycan and laminin-alpha2 chain in the rat peripheral nerve during development. Exp. Neurol. 174:2002;109-117.
37. Matsumura K., Yamada H., Shimizu T., Campbell K.P. Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve. FEBS Lett. 334:1993;281-285.
38. Matsumura K., Yamada H., Saito F., Sunada Y., Shimizu T. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromuscul. Disord. 7:1997;7-12.
39. Melendez-Vasquez C.V., Rios J.C., Zanazzi G., Lambert S., Bretscher A., Salzer J.L. Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes. Proc. Natl. Acad. Sci. USA. 98:2001;1235-1240.
40. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., Dollar J., Nishino I., Kelley R.I., Somer H.et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 418:2002;417-422.
41. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., Cohn R.D., Ross-Barta S.E., Westra S., Williamson R.A.et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 418:2002;422-425.
42. 3K) mice. Glia. 35:2001;101-110.
43. Ohlendieck K., Campbell K.P. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell Biol. 115:1991;1685-1694.
44. Okada E., Mizuhira V., Nakamura H. Abnormally combined myelinated and unmyelinated nerves in dystrophic mice. J. Neurol. Sci. 33:1977;243-249.
45. Peles E., Salzer J.L. Molecular domains of myelinated axons. Curr. Opin. Neurobiol. 10:2000;558-565.
46. Previtali S.C., Feltri M.L., Archelos J.J., Quattrini A., Wrabetz L., Hartung H. Role of integrins in the peripheral nervous system. Prog. Neurobiol. 64:2001;35-49.
47. Rambukkana A., Yamada H., Zanazzi G., Mathus T., Salzer J.L., Yurchenco P.D., Campbell K.P., Fischetti V.A. Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science. 282:1998;2076-2079.
48. Rambukkana A., Zanazzi G., Tapino N., Salzer J.L. Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells. Science. 296:2002;927-931.
49. Rasband M.N., Trimmer J.S. Developmental clustering of ion channels at and near the node of Ranvier. Dev. Biol. 236:2001;5-16.
50. Ratcliffe C.F., Westenbroek R.E., Curtis R., Catterall W.A. Sodium channel beta1 and beta3 subunits associate with neurofascin through their extracellular immunoglobulin-like domain. J. Cell Biol. 154:2001;427-434.
51. Saito F., Masaki T., Kamakura K., Anderson L.V., Fujita S., Fukuta-Ohi H., Sunada Y., Shimizu T., Matsumura K. Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells. J. Biol. Chem. 274:1999;8240-8246.
52. Scherer S.S., Arroyo E.J. Recent progress on the molecular organization of myelinated axons. J. Peripher. Nerv. Syst. 7:2002;1-12.
53. Scherer S.S., Xu T., Crino P., Arroyo E.J., Gutmann D.H. Ezrin, radixin, and moesin are components of Schwann cell microvilli. J. Neurosci. Res. 65:2001;150-164.
54. Sherman D.L., Fabrizi C., Gillespie C.S., Brophy P.J. Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron. 30:2001;677-687.
55. Shetty V. Polyaxonal myelination in a human leprous nerve. Int. J. Lepr. Other Mycobact. Dis. 63:1995;104-105.
56. Tait S., Gunn-Moore F., Collinson J.M., Huang J., Lubetzki C., Pedraza L., Sherman D.L., Colman D.R., Brophy P.J. An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J. Cell Biol. 150:2000;657-666.
57. Thouvarecq R., Protais P., Jouen F., Caston J. Influence of cholinergic system on motor learning during aging in mice. Behav. Brain Res. 118:2001;209-218.
58. Tsiper M.V., Yurchenco P.D. Laminin assembles into separate basement membrane and fibrillar matrices in Schwann Cells. J. Cell Sci. 115:2002;1005-1015.
59. Wacnik P.W., Eikmeier L.J., Ruggles T.R., Ramnaraine M.L., Walcheck B.K., Beitz A.J., Wilcox G.L. Functional interactions between tumor and peripheral nerve. morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain J. Neurosci. 21:2001;9355-9366.
60. Williamson R.A., Henry M.D., Daniels K.J., Hrstka R.F., Lee J.C., Sunada Y., Ibraghimov-Beskrovnaya O., Campbell K.P. Dystroglycan is essential for early embryonic development. disruption of Reichert's membrane in Dag1-null mice Hum. Mol. Genet. 6:1997;831-841.
61. Yamada H., Shimizu T., Tanaka T., Campbell K.P., Matsumura K. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett. 352:1994;49-53.
62. Yamada H., Denzer A.J., Hori H., Tanaka T., Anderson L.V., Fujita S., Fukuta-Ohi H., Shimizu T., Ruegg M.A., Matsumura K. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J. Biol. Chem. 271:1996;23418-23423.
63. Yeomans D.C., Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat. electrophysiological evidence Pain. 68:1996;141-150.